An international collaboration, using data from more than 100,000 women with breast cancer from 58 epidemiological studies worldwide, has found that using MHT is associated with an increased risk of breast cancer, and that ...
Aug 30, 2019
0
3
(HealthDay)—Hormone therapy (HT) does not significantly impact muscle mass in postmenopausal women, according to a review published online Aug. 28 in JAMA Network Open.
Aug 29, 2019
0
3
BRCA1 and BRCA2 genetic variants are a clinically important risk factor for the development of ovarian and breast cancer, and women who carry these variants have a lifetime risk of ovarian cancer of 39%-44% and 11%-17%, respectively.
Aug 12, 2019
0
6
A company in the United Kingdom is offering women a procedure it says can delay menopause up to 20 years and allow women to delay having babies.
Aug 8, 2019
0
4
Scientists at Magee-Womens Research Institute (MWRI), collaborating with clinicians at UPMC Magee-Womens Hospital and UPMC Children's Hospital of Pittsburgh report two cases in which young transgender women attempted to recover ...
Aug 5, 2019
0
1
Women with breast cancer should start postoperative chemotherapy, when recommended, ideally within four months of their cancer diagnosis because new study findings show that waiting longer is associated with poorer overall ...
Jul 22, 2019
0
4
Sleep disturbances are a frequent complaint of women in the menopause transition and postmenopause. A new study demonstrates that women with premature ovarian insufficiency (POI) who are receiving hormone therapy have poorer ...
Jul 16, 2019
0
10
Transgender care is swiftly evolving, and primary care providers face a greater need to be clear about their roles and when to seek the support of specialists, according to the latest review by Mount Sinai experts in the ...
Jul 1, 2019
0
0
Millions of patients with incurable breast cancer could benefit from Welsh-led research which shows it is possible to control the cancer for twice as long by combing an investigational therapy with standard treatment.
Jun 10, 2019
0
3
A UCLA-led study has found that using a drug called ribociclib in combination with a common hormone therapy may help premenopausal women with the most common type of breast cancer live longer than if they only receive the ...
Jun 3, 2019
0
2
